#32026R1150EU renews authorisation of neohesperidine dihydrochalcone as an animal feed flavouring
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The regulation renews the EU authorisation for neohesperidine dihydrochalcone as a flavouring compound in feed for piglets, pigs for fattening, calves, sheep, food-producing finfish, ornamental finfish and dogs. It replaces the previous 2015 authorisation and keeps the additive available for use under authorised conditions. Feed additive producers, feed manufacturers, livestock operators, fish producers and pet food businesses can continue using or placing the additive on the market if they follow the updated authorisation terms. EFSA found it remains safe for the target animals, consumers and the environment, but noted that inhalation exposure is likely, so handling controls remain important for workers.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Renews the EU authorisation of neohesperidine dihydrochalcone as a sensory feed additive and flavouring compound.
- Covers use in feed for piglets, pigs for fattening, calves, sheep, food-producing finfish, ornamental finfish and dogs.
- Repeals the previous authorisation under Implementing Regulation (EU) 2015/264.
Obligations
What this law requires
Place on the market and use neohesperidine dihydrochalcone only as a sensory additive/flavouring compound for piglets, pigs for fattening, calves, sheep, food-producing finfish, ornamental finfish and dogs, subject to the Annex conditions.
Do not exceed 35 mg of neohesperidine dihydrochalcone active substance per kg of complete feed with 12% moisture content for each authorised target species or category.
Ensure directions for use of the additive and premixtures indicate the storage conditions and stability to heat treatment.
For users of the additive and premixtures, establish operational procedures and organisational measures to address potential risks resulting from use of neohesperidine dihydrochalcone.
Where risks from use of the additive or premixtures cannot be eliminated by operational procedures and organisational measures, use the additive and premixtures with personal breathing protective equipment.